Home/Filings/4/0001104659-24-002375
4//SEC Filing

Lin Tai-An 4

Accession 0001104659-24-002375

CIK 0001773427other

Filed

Jan 7, 7:00 PM ET

Accepted

Jan 8, 9:10 PM ET

Size

7.6 KB

Accession

0001104659-24-002375

Insider Transaction Report

Form 4
Period: 2024-01-04
Lin Tai-An
Chief Scientific Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-01-04+15,00015,000 total
    Exercise: $38.40Exp: 2034-01-03Common Stock (15,000 underlying)
  • Award

    Common Stock

    2024-01-04+5,28929,289 total
Footnotes (2)
  • [F1]This transaction represents a grant of restricted stock units ("RSUs"). The RSUs shall vest as follows: thirty-three percent (33%) to vest on January 4, 2025, another thirty-three percent (33%) to vest on January 4, 2026 and the remaining thirty-four percent (34%) to vest on January 4, 2027, subject to continued service to the Issuer by the Reporting Person through each applicable vesting date.
  • [F2]This option shall vest in forty-eight (48) equal monthly installments following January 4, 2024, subject to continued service to the Issuer by the Reporting Person through each applicable vesting date.

Issuer

SpringWorks Therapeutics, Inc.

CIK 0001773427

Entity typeother

Related Parties

1
  • filerCIK 0001991985

Filing Metadata

Form type
4
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 9:10 PM ET
Size
7.6 KB